Akzo Nobel India [AKZOINDIA] vs Kansai Nerolac [KANSAINER] Detailed Stock Comparison

Akzo Nobel India

NSE
Loading...

Kansai Nerolac

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Akzo Nobel India wins in 8 metrics, Kansai Nerolac wins in 12 metrics, with 0 ties. Kansai Nerolac appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricAkzo Nobel IndiaKansai NerolacBetter
P/E Ratio (TTM)37.9018.07Kansai Nerolac
Price-to-Book Ratio11.563.18Kansai Nerolac
Debt-to-Equity Ratio4.674.63Kansai Nerolac
PEG Ratio-1.84-3.98Kansai Nerolac
EV/EBITDA25.4821.40Kansai Nerolac
Profit Margin (TTM)10.02%14.43%Kansai Nerolac
Operating Margin (TTM)11.68%11.57%Akzo Nobel India
EBITDA Margin (TTM)11.68%11.57%Akzo Nobel India
Return on Equity32.29%17.85%Akzo Nobel India
Return on Assets (TTM)14.79%13.91%Akzo Nobel India
Free Cash Flow (TTM)$2.05B$3.46BKansai Nerolac
Dividend Yield2.65%90.31%Kansai Nerolac
1-Year Return-10.31%-20.41%Akzo Nobel India
Price-to-Sales Ratio (TTM)3.802.61Kansai Nerolac
Enterprise Value$151.49B$185.98BKansai Nerolac
EV/Revenue Ratio3.742.37Kansai Nerolac
Gross Profit Margin (TTM)42.84%36.08%Akzo Nobel India
Revenue per Share (TTM)$889$97Akzo Nobel India
Earnings per Share (Diluted)$89.09$14.00Akzo Nobel India
Beta (Stock Volatility)0.280.01Kansai Nerolac
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Akzo Nobel India vs Kansai Nerolac Stock Performance Analysis

Loading Price Chart...

Akzo Nobel India
Kansai Nerolac
Akzo Nobel India Stock Overview | Kansai Nerolac Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Akzo Nobel India0.49%0.36%-0.87%4.02%1.16%-4.79%
Kansai Nerolac-2.68%0.47%4.98%3.06%1.06%-6.69%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Akzo Nobel India-10.31%53.82%55.68%143.14%268.79%923.59%
Kansai Nerolac-20.41%-49.72%-49.78%2.84%142.83%589.28%

News Based Sentiment: Akzo Nobel India vs Kansai Nerolac

Akzo Nobel India

News based Sentiment: MIXED

The CCI approval of the JSW acquisition is a major positive development, but ongoing regulatory challenges and mixed analyst sentiment create a complex investment picture. The month represents a significant turning point with potential for both gains and risks, making it a noteworthy period for investors.

View Akzo Nobel India News Sentiment Analysis

Kansai Nerolac

News based Sentiment: MIXED

September brought a significant competitive challenge with the JSW-Akzo Nobel deal, alongside mixed signals regarding Kansai Nerolac’s stock performance and analyst sentiment. While EPS growth remains strong, long-term shareholder returns have been disappointing, creating a complex investment picture.

View Kansai Nerolac News Sentiment Analysis

Performance & Financial Health Analysis: Akzo Nobel India vs Kansai Nerolac

MetricAKZOINDIAKANSAINER
Market Information
Market Cap i₹153.89B₹199.26B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i14,509897,994
90 Day Avg. Volume i22,770643,087
Last Close₹3,392.70₹246.21
52 Week Range₹3,022.00 - ₹4,674.00₹218.20 - ₹313.50
% from 52W High-27.41%-21.46%
All-Time High₹4,674.00 (Oct 28, 2024)₹680.00 (Jan 18, 2021)
% from All-Time High-27.41%-63.79%
Growth Metrics
Quarterly Revenue Growth-0.04%0.01%
Quarterly Earnings Growth-0.21%-0.04%
Financial Health
Profit Margin (TTM) i0.10%0.14%
Operating Margin (TTM) i0.12%0.12%
Return on Equity (TTM) i0.32%0.18%
Debt to Equity (MRQ) i4.674.63
Cash & Liquidity
Book Value per Share (MRQ)₹292.09₹79.45
Cash per Share (MRQ)₹63.35₹26.39
Operating Cash Flow (TTM) i₹3.76B₹14.19B
Levered Free Cash Flow (TTM) i₹4.30B₹11.43B
Dividends
Last 12-Month Dividend Yield i2.65%90.31%
Last 12-Month Dividend i₹100.00₹215.75

Valuation & Enterprise Metrics Analysis: Akzo Nobel India vs Kansai Nerolac

MetricAKZOINDIAKANSAINER
Price Ratios
P/E Ratio (TTM) i37.9018.07
Forward P/E i30.8625.15
PEG Ratio i-1.84-3.98
Price to Sales (TTM) i3.802.61
Price to Book (MRQ) i11.563.18
Market Capitalization
Market Capitalization i₹153.89B₹199.26B
Enterprise Value i₹151.49B₹185.98B
Enterprise Value Metrics
Enterprise to Revenue i3.742.37
Enterprise to EBITDA i25.4821.40
Risk & Other Metrics
Beta i0.280.01
Book Value per Share (MRQ) i₹292.09₹79.45

Financial Statements Comparison: Akzo Nobel India vs Kansai Nerolac

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)AKZOINDIAKANSAINER
Revenue/Sales i₹9.95B₹21.62B
Cost of Goods Sold i₹5.69B₹13.82B
Gross Profit i₹4.26B₹7.80B
Research & Development iN/AN/A
Operating Income (EBIT) i₹1.16B₹2.50B
EBITDA i₹1.44B₹3.56B
Pre-Tax Income i₹1.23B₹2.95B
Income Tax i₹315.00M₹798.70M
Net Income (Profit) i₹910.00M₹2.16B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)AKZOINDIAKANSAINER
Cash & Equivalents i₹2.48B₹940.00M
Total Current Assets i₹20.13B₹53.52B
Total Current Liabilities i₹14.50B₹14.51B
Long-Term Debt i₹448.00M₹1.75B
Total Shareholders Equity i₹13.30B₹64.04B
Retained Earnings i₹7.75B₹58.42B
Property, Plant & Equipment i₹2.17B₹837.10M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)AKZOINDIAKANSAINER
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricAKZOINDIAKANSAINER
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i14,509897,994
Average Daily Volume (90 Day) i22,770643,087
Shares Outstanding i45.54M808.44M
Float Shares i9.02M201.21M
% Held by Insiders i0.80%0.75%
% Held by Institutions i0.13%0.11%

Dividend Analysis & Yield Comparison: Akzo Nobel India vs Kansai Nerolac

MetricAKZOINDIAKANSAINER
Last 12-Month Dividend i₹100.00₹215.75
Last 12-Month Dividend Yield i2.65%90.31%
3-Year Avg Annual Dividend i₹91.67₹72.73
3-Year Avg Dividend Yield i1.40%29.65%
3-Year Total Dividends i₹275.00₹218.20
Ex-Dividend DateJul 25, 2025Jun 23, 2025